Please wait

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13D/A 0001675236 XXXXXXXX LIVE 7 Common Stock, $0.001 Par Value 09/13/2024 false 0001539029 185063104 CLEARSIDE BIOMEDICAL, INC. 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 Clay Thorp (919) 484-0730 280 S. Mangum Street, Suite 350 Durham NC 27701 0001675236 N Hatteras Venture Advisors IV SBIC, LLC OO N X1 0.00 0.00 0.00 0.00 0.00 N 0 CO Y Hatteras Venture Partners IV SBIC, LP OO N X1 0.00 0.00 0.00 0.00 0.00 N 0 CO Y Hatteras Venture Advisors IV, LLC OO N X1 0.00 0.00 0.00 0.00 0.00 N 0 CO Y Hatteras Venture Partners IV, LP OO N X1 0.00 0.00 0.00 0.00 0.00 N 0 CO Y Hatteras NC Fund, LP OO N X1 0.00 0.00 0.00 0.00 0.00 N 0 CO Y John C. Crumpler OO N X1 125793.00 0.00 125793.00 0.00 125793.00 N 0.2 IN Y Robert A. Ingram OO N X1 130881.00 0.00 130881.00 0.00 130881.00 N 0.2 IN Y Kenneth B. Lee OO N X1 86324.00 0.00 86324.00 0.00 86324.00 N 0.1 IN Y Clay B. Thorp OO N X1 313641.00 0.00 313641.00 0.00 313641.00 N 0.4 IN Includes 152,500 shares of Common Stock subject to options held by Mr. Thorp that are exercisable within 60 days of February 21, 2025. Y Douglas Reed OO N X1 127011.00 0.00 127011.00 0.00 127011.00 N 0.2 IN Common Stock, $0.001 Par Value CLEARSIDE BIOMEDICAL, INC. 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 This Amendment No. 7 on Schedule 13D amends the statement on Schedule 13D, dated June 7, 2016, which relates to the Common Stock, par value $0.001 per share (the "Common Stock") of Clearside Biomedical, Inc. (the "Issuer") which was previously amended on Schedule 13D/A, dated January 20 and April 17, 2017, March 21, 2018, July 17 and December 4, 2019, and January 4, 2023 filed by: Hatteras Venture Advisors IV SBIC, LLC ("HVA SBIC") Hatteras Venture Partners IV SBIC, LP ("HVP SBIC") Hatteras Venture Advisors IV, LLC ("HVA IV") Hatteras Venture Partners IV, LP ("HVP IV") Hatteras NC Fund, LP ("Hatteras Fund") John C. Crumpler Robert A. Ingram Kenneth B. Lee Clay B. Thorp Douglas Reed (collectively, the "Reporting Persons"). Except as expressly amended below, the Schedule 13D, dated June 7, 2016, remains in effect. HVA SBIC-- 0 or 0% HVP SBIC -- 0 or 0% HVA IV-- 0 or 0% HVP IV -- 0 or 0% Hatteras Fund-- 0 or 0% John C. Crumpler -- 125,793 or 0.2% Robert A. Ingram -- 130,881 or 0.2% Kenneth B. Lee -- 86,324 or 0.1% Clay B. Thorp -- 313,641 or 0.4% Douglas Reed -- 127, 011 or 0.2% (i) Sole power to vote or to direct the vote HVA SBIC-- 0 HVP SBIC -- 0 HVA IV-- 0 HVP IV -- 0 Hatteras Fund-- 0 John C. Crumpler -- 125,793 Robert A. Ingram -- 130,881 Kenneth B. Lee -- 86,324 Clay B. Thorp -- 313,641 Douglas Reed -- 127, 011 (iii) Sole power to dispose or to direct the disposition of HVA SBIC-- 0 HVP SBIC -- 0 HVA IV-- 0 HVP IV -- 0 Hatteras Fund-- 0 John C. Crumpler -- 125,793 Robert A. Ingram -- 130,881 Kenneth B. Lee -- 86,324 Clay B. Thorp -- 313,641 Douglas Reed -- 127, 011 (iv) Shared power to dispose or to direct the disposition of HVA SBIC-- 0 HVP SBIC -- 0 HVA IV-- 0 HVP IV -- 0 Hatteras Fund-- 0 John C. Crumpler -- 0 Robert A. Ingram -- 0 Kenneth B. Lee -- 0 Clay B. Thorp -- 0 Douglas Reed -- 0 (ii) Shared power to vote or to direct the vote HVA SBIC-- 0 HVP SBIC -- 0 HVA IV-- 0 HVP IV -- 0 Hatteras Fund-- 0 John C. Crumpler -- 0 Robert A. Ingram -- 0 Kenneth B. Lee -- 0 Clay B. Thorp -- 0 Douglas Reed -- 0 September 13, 2024 Hatteras Venture Advisors IV SBIC, LLC /s/ Clay B. Thorp Clay B. Thorp, Manager 02/21/2025 Hatteras Venture Partners IV SBIC, LP /s/ Clay B. Thorp Clay B. Thorp, Manager 02/21/2025 Hatteras Venture Advisors IV, LLC /s/ Clay B. Thorp Clay B. Thorp, Manager 02/21/2025 Hatteras Venture Partners IV, LP /s/ Clay B. Thorp Clay B. Thorp, Manager 02/21/2025 Hatteras NC Fund, LP /s/ Clay B. Thorp Clay B. Thorp, Manager 02/21/2025 John C. Crumpler /s/ Clay B. Thorp Clay B. Thorp, by Power of Attorney 02/21/2025 Robert A. Ingram /s/ Clay B. Thorp Clay B. Thorp, by Power of Attorney 02/21/2025 Kenneth B. Lee /s/ Clay B. Thorp Clay B. Thorp, by Power of Attorney 02/21/2025 Clay B. Thorp /s/ Clay B. Thorp Clay B. Thorp 02/21/2025 Douglas Reed /s/ Clay B. Thorp Clay B. Thorp, by Power of Attorney 02/21/2025 This Amendment No. 7 to Schedule 13D was executed by Clay B. Thorp on behalf of the individuals listed above pursuant to a Power of Attorney a copy of which was previously filed with the Reporting Person's Schedule 13D filed with the SEC on June 17, 2016 and as amended on February 8 and April 25, 2017, March 21, 2018, July 17 and December 4, 2019 and January 4, 2023.